Archive · 20 Jul 2025
New Book Reveals Dark Secrets of Johnson & Johnson
A new book called 'No More Tears' is talking about the problems with a big medicine company called Johnson & Johnson.
It says the company hid important information about some of its products like Tylenol and talcum powder.
The author says the government agency in charge of making sure drugs are safe didn't do its job properly.
The book also talks about how the company gave incentives to doctors.
It also explains that sometimes, companies care more about making money than making safe products.
Gardiner Harris's book 'No More Tears' exposes alleged cover-ups and negligence by Johnson & Johnson.
The book highlights issues with products like Tylenol, talcum powder, and prescription drugs such as EPO and Risperdal.
Harris criticizes the USFDA for alleged incompetence and corruption in its oversight of the pharmaceutical industry.
The book details instances of pharmaceutical companies incentivizing doctors and funding research studies.
The book argues that the profit-driven focus of pharmaceutical companies can lead to negligence and the neglect of product safety.
- Who
- Investigative journalist Gardiner Harris wrote the book. It concerns Johnson & Johnson, its products, doctors, and the USFDA.
- What
- The book 'No More Tears' investigates alleged misconduct and cover-ups by Johnson & Johnson and critiques USFDA's role.
- When
- The book covers events from 1970s onward, with specific examples cited across various years.
- Where
- Focus is on the actions and impact within the United States and its pharmaceutical market.
- Why
- The book reveals issues with products, questions safety and oversight, and shows how profit can affect product decisions.
Viewpoint of the Book
Missing Viewpoints
Product Safety vs. Profit
Viewpoint of the Book
Johnson & Johnson prioritized profits over consumer safety and hid issues with its products.
Missing Viewpoints
The article presents allegations of corporate misconduct without providing Johnson & Johnson's defense or alternative view.
Regulatory Oversight
Viewpoint of the Book
The USFDA failed in its oversight role, allowing problematic products to remain on the market.
Missing Viewpoints
The USFDA's performance is criticized, but the article doesn't provide details about the agency's perspective or reasons for their actions.
- Book Title
- No More Tears
- Author
- Gardiner Harris
- Publisher
- Penguin Random House
- Pages
- 444
- Price
- ₹899
- Publication Date
- July 16, 2025